Actinium Pharmaceuticals
ATNM • AMEX
Actinium Pharmaceuticals is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Sandesh C. Seth, with a market cap of $36.2M.
CEOSandesh C. Seth
Market Cap$36.2M
Biotechnology
Healthcare
Employees49.0
Websiteactiniumpharma.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Actinium Pharmaceuticals
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.19
Earnings History
Past 12 earnings reports for Actinium Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.16Est: -$0.23 | +30.4% | $90.0K | — |  10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.22Est: -$0.30 | +26.7% | - | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.51Est: -$0.36 | -41.7% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.21Est: -$0.29 | +27.6% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.37Est: -$0.36 | -2.8% | - | — | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.38Est: -$0.40 | +5.0% | - | — | 10-Q |
| Apr 26, 2024 | Q1 2024 | -$0.31Est: -$0.52 | +40.4% | - | — | 10-Q |
| Mar 29, 2024 | Q4 2023 | -$0.33Est: -$0.54 | +38.9% | $81.0K | — | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.49Est: -$0.51 | +3.9% | -Est: $570.0K | -100.0% | — |
| Aug 14, 2023 | Q2 2023 | -$0.58 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.43 | — | - | — | 10-Q |
| Apr 3, 2023 | Q4 2022 | -$0.43Est: -$0.35 | -22.9% | -Est: $1.0M | -100.0% | — |